Apr 07, 2016 7:00 am EDT Heat Biologics Announces Cost-Saving Measures and Focused Corporate Strategy to Achieve Important Clinical Milestones
Mar 30, 2016 7:00 am EDT Heat Biologics to Participate in the 6th Annual Cancer Immunotherapy: A Long-Awaited Reality Conference
Mar 09, 2016 7:00 am EST Heat Biologics’ CSO to Participate in the 27th Annual Cancer Progress Conference by Defined Health
Mar 07, 2016 4:05 pm EST Heat Biologics Presents Positive ComPACT Preclinical Data at the Keystone Symposia
Feb 25, 2016 7:00 am EST Heat Biologics Provides Update on Its HS-410 Phase 2 Monotherapy Bladder Cancer Trial Arm